Welcome to our dedicated page for Helo news (Ticker: HLOC), a resource for investors and traders seeking the latest updates and insights on Helo stock.
Helo Corp (HLOC) regularly issues news updates as a data-driven wellness technology company focused on AI-enabled wearables, biodata platforms and personalized nutrition devices. Its announcements describe ongoing development of the Helo AI™ platform, Life Sensing Technology® wearables and products such as BioStrip™, the BioSense health band™ and the NutraMatic™ personalized nutrition device.
Recent news has highlighted the planned market launch of the BioSense Watch, a thin wearable that Helo describes as its first device with an embedded personal air sensor designed to detect total volatile organic compounds (TVOC), estimate CO2 and monitor indoor and outdoor air quality near the wearer. The company has also reported on NutraMatic, a countertop device intended to provide AI-optimized, personalized combinations of nutrition supplements based on a user’s current biodata status.
Helo’s press releases also cover corporate developments and events, such as executive appointments, participation in investor conferences and presentations at gatherings like the Emerging Growth Conference and the Moneyshow®. In these forums, management has discussed the company’s refocused strategic direction, progress on Helo AI, NutraMatic production status and investigational studies designed to train its AI knowledge domain.
Investors and observers using the HLOC news page can review these updates to follow Helo’s product pipeline, technology initiatives, restructuring efforts and partnerships, including its blockchain-related agreement for de-identified data storage and potential user data monetization. The news feed provides a centralized view of Helo’s disclosed milestones and communications with the market.
Helo Corp. (HLOC) has announced funding of £150,000 in convertible debt to support the development of santéPatch, a technology aimed at monitoring micronutrient levels in users. This investment is part of Helo's strategy to enhance its precision nutrition offerings through its subsidiary, Vyvo Technology Corp. With the precision nutrition market expected to grow from over $8 billion in 2020 to over $24 billion by 2028, Helo aims to leverage this technology to provide personalized nutrition data, thereby improving customer health outcomes.
Helo Corp (OTC PINK:HLOC) has launched its BIA technology worldwide under the Vyvo brand, enabling users to measure body composition through a painless, non-invasive method. The Vyvo LifeWatch 2.0 and Leggera 2.0 scales incorporate proprietary algorithms for comprehensive body analysis. This innovation aims to address rising obesity rates and promote better wellness. Helo emphasizes its commitment to empowering users with actionable insights into their health and well-being.
Helo Corp. (OTC PINK:HLOC) announced that Vyvo Network Japan KK has won the inaugural Helo Chairman's Award for 2021. The award recognizes exceptional performance with significant impacts on Vyvo's business. It was granted by Helo's Chairman, Fabio Galdi, who commended the Japanese team for their resilience and impressive financial results amidst challenging conditions. The award includes a bonus for January 2022, adding to existing employee performance bonuses. Helo continues to focus on wellness technology and digital health innovations.
Helo Corp (OTC PINK:HLOC) has expanded its operations by opening larger offices for three subsidiaries in the US and Asia, as part of its strategy for continued growth following record results in 2021. The company has doubled its staff and is preparing to enter new markets in 2022 through acquisitions, joint ventures, or organic growth. CEO Sean McVeigh emphasized the importance of these expansions for employee safety and operational support. Helo's advancements in wellness technology position it well for sustained growth while fostering the Digital Health Sharing Economy.
Helo Corp. (OTC PINK:HLOC) has been recognized by Deloitte as one of the fastest-growing technology companies in North America, achieving a remarkable 679% revenue growth from 2017 to 2020. This award reflects Helo's innovative technology and updated business model focusing on digital health and wellness products. CEO Seán McVeigh highlighted the dedication of their employees in achieving this milestone. Helo's Life Sensing Technology™ integrates advanced bio-parameters, allowing users to earn revenue through utility tokens while contributing to health research.
Helo Corp. (OTC PINK:HLOC) reported impressive third-quarter results for 2021, featuring a revenue surge of 1395% to $52.8 million, attributed to its new business model promoting wellness products via the Vyvo brand. The gross profit rose by $17.4 million to $18.2 million, with a gross margin increase of 110 basis points to 34%. Operating income improved to $10.7 million, and net income reached $9.9 million, translating to a positive EPS of $0.11. The company's total assets increased by $17 million to $23.5 million.
Helo Corp. (OTC PINK:HLOC) has announced a significant update to its Vyvo Smart app, enabling rapid, non-invasive vascular age assessment for all Vyvo Life Watch 2 users globally. This innovation employs patent-pending technology to analyze fingertip signals in under a minute, potentially aiding in cardiovascular disease detection. CEO Seán McVeigh emphasized the importance of this feature, noting its uniqueness and significant health implications. The move aligns with efforts to improve wellness and empower users with personalized health insights.